Galera Therapeutics Raises $150 Million for GC4419 Phase 3 Trial and Pre-Commercialization Activities in Lead Indication

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2MNbO5g
via IFTTT